These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 23357157

  • 1. Differential effects of lipoprotein apheresis by lipidfiltration or dextran sulfate adsorption on lipidomic profile.
    Gräßler J, Kopprasch S, Passauer J, Fischer S, Schuhmann K, Bergmann S, Siegert G, Shevchenko A, Bornstein SR, Julius U.
    Atheroscler Suppl; 2013 Jan; 14(1):151-5. PubMed ID: 23357157
    [Abstract] [Full Text] [Related]

  • 2. Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patients.
    Kopprasch S, Bornstein SR, Schwarz PE, Bergmann S, Julius U, Graessler J.
    Atheroscler Suppl; 2013 Jan; 14(1):157-60. PubMed ID: 23357158
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beyond lowering circulating LDL: apheresis-induced changes of systemic oxidative stress markers by four different techniques.
    Kopprasch S, Graessler J, Bornstein SR, Schwarz PE, Tselmin S, Frind A, Poberschin I, Julius U.
    Atheroscler Suppl; 2009 Dec 29; 10(5):34-8. PubMed ID: 20129371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How to optimize lipoprotein apheresis treatment--a second look.
    Schettler V, Neumann CL, Hagenah GC, Schulz EG, Wieland E.
    Atheroscler Suppl; 2013 Jan 29; 14(1):89-92. PubMed ID: 23357148
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
    Sosland RP, Gollub SB, Wilson DB, Moriarty PM.
    Ther Apher Dial; 2010 Apr 29; 14(2):218-21. PubMed ID: 20438545
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of lipid reduction with DALI and MONET.
    Ramlow W, Röseler E, Heigl F, Spitthöver R, Ringel J, Schmitz G, Heinzler R, Abdul-Rahman N, Leistikow F, Himmelsbach F, Schettler V, Pham J, Kozik-Jaromin J.
    Atheroscler Suppl; 2017 Nov 29; 30():217-224. PubMed ID: 29096841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of different low-density lipoprotein apheresis methods.
    Parhofer KG, Geiss HC, Schwandt P.
    Ther Apher; 2000 Oct 29; 4(5):382-5. PubMed ID: 11111821
    [Abstract] [Full Text] [Related]

  • 18. [LDL cholesterol apheresis by adsorption to dextran sulfate].
    Grunewald RW, Ditschuneit HH, Klein J, König W, Grunewald JM, Franz HE.
    Infusionsther Transfusionsmed; 1992 Aug 29; 19(4):194-6. PubMed ID: 1422078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.